Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PHARMACEUTICAL COMPOSITION CONTAINING PIMITESPIB
Document Type and Number:
WIPO Patent Application WO/2023/238929
Kind Code:
A1
Abstract:
Provided is a pharmaceutical composition containing compound 1 and having excellent disintegrability and bioavailability.　This pharmaceutical composition contains crystalline cellulose and a granulated substance containing 3-ethyl-4-{4-[4-(1-methyl-1H-pyrazol-4-yl)-1H-imidazol-1-yl]-3-(propan-2-yl)-1H-pyrazolo[3,4-b]pyridine-1-yl}benzamide or a pharmaceutically acceptable salt thereof, and has a disintegration time of 360 seconds or less in a coated tablet state.

More Like This:
JP4449104Sugar-coated solid composition
WO/1994/003160PELLETISED PHARMACEUTICAL COMPOSITION
JP6403742Oral opioid agonist preparation resistant to external pressure
Inventors:
NISHIYAMA TETSUYA (JP)
NIKI YUUICHIROU (JP)
Application Number:
PCT/JP2023/021535
Publication Date:
December 14, 2023
Filing Date:
June 09, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
TAIHO PHARMACEUTICAL CO LTD (JP)
International Classes:
A61K9/36; A61K31/437; A61K47/38; A61P35/00; A61P43/00
Domestic Patent References:
WO2019220512A12019-11-21
WO2016181990A12016-11-17
WO2012161240A12012-11-29
Foreign References:
JP2021167346A2021-10-21
JP2013510875A2013-03-28
JP2001240540A2001-09-04
Attorney, Agent or Firm:
ARUGA PATENT OFFICE (JP)
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: PLASMA MEASUREMENT DEVICE

Next Patent: ANALOGUES OF AZABICYCLIC COMPOUNDS